Composition
- Active ingredients
- LEVAMLODIPINE MALEATE EQ 2.5MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LEVAMLODIPINE MALEATE EQ 2.5MG BASE · TabletThis page
- LEVAMLODIPINE MALEATE EQ 5MG BASE · TabletNDA212895-003 · Discontinued
- LEVAMLODIPINE MALEATE EQ 1.25MG BASE · TabletNDA212895-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA212895.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Conjupri
- Active substance
- levamlodipine maleate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- CSPC Ouyi
- Status
- Discontinued
- FDA approval
- 19 Dec 2019
- Application
- NDA212895-002